Sell any drug, in any market.

Firstocean is the AI-native platform to plan, launch and scale your asset worldwide.

Tell us about your drug

What we do

A third of a drug's lifetime value sits outside the US and Europe. Most biotechs never collect it.

We take your drug into every market where it has demand, across the Gulf, Latin America and Southeast Asia, at no upfront cost.

Market entry

We find the markets where your drug has demand and act as your business development team. One agreement covers all of them.

A team working around a table with laptops and printed reports

Pricing and reimbursement

We secure the price and the reimbursement in every territory we enter, so health systems pay for your innovation.

Distribution

We move your drug through specialist partners until it reaches every patient who needs it, and we keep it safe on the market for as long as it sells.

Work with us

A strategist marking territories on a wall map

1

Assessment

We assess the assets in your portfolio free, no strings attached. Our models forecast patients, price and the registration route, and we only propose a market where the forecast supports a launch.

Two professionals reviewing a printed agreement at a table

2

Terms

One agreement. It sets the territories, the supply, and the transfer price. Your intellectual property stays yours. There is no upfront fee.

A physician reading the label of a prescription medicine bottle

3

Registration

Regulators in our markets now accept FDA and EMA approvals: no local trials, no repeat review. Software drafts each local file from your dossier, a licensed professional approves it, and approval lands in months, not years.

Medicine cartons and trays of vials on fulfillment shelving

4

Launch

We take on price, reimbursement and supply into the channel. You sell through us and keep the best margins of any commercialization partner.

An elderly man and his granddaughter sitting together in the sun

5

The life of the product

Safety, renewals and label maintenance stay with us for as long as the product sells, and a licensed professional approves every safety decision. The agreement does not end at approval.

A new kind of platform

Pharma veterans and world-class engineers: the first AI-native commercialization team.

Launch costs cut by 80%.

Filed 10x faster.

Not a single hour of your team's time.

A professional reading a report at a desk by a tall window

Our advisors ran emerging markets at Pfizer and business development at Johnson & Johnson.

A scientist in a white lab coat holding a vial up to the light

A novel drug, across the globe.

Tell us about your drug

Tell us the asset and the stage. You get a free assessment of what it is worth in every market.

A handshake between two professionals in warm sunlight